Peter C. Wierenga

737 total citations
18 papers, 522 citations indexed

About

Peter C. Wierenga is a scholar working on Geriatrics and Gerontology, Emergency Medical Services and Economics and Econometrics. According to data from OpenAlex, Peter C. Wierenga has authored 18 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Geriatrics and Gerontology, 8 papers in Emergency Medical Services and 6 papers in Economics and Econometrics. Recurrent topics in Peter C. Wierenga's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Patient Safety and Medication Errors (8 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Peter C. Wierenga is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Patient Safety and Medication Errors (8 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Peter C. Wierenga collaborates with scholars based in Netherlands, Iran and Canada. Peter C. Wierenga's co-authors include Reza Khajouei, Susanne M. Smorenburg, Ameen Abu‐Hanna, Marjan Askari, Arie Hasman, Loraine Lie‐A‐Huen, Evert de Jonge, Saied Eslami, Joanna E. Klopotowska and Marcel G. W. Dijkgraaf and has published in prestigious journals such as PLoS ONE, BMC Health Services Research and Drug Safety.

In The Last Decade

Peter C. Wierenga

18 papers receiving 503 citations

Peers

Countries citing papers authored by Peter C. Wierenga

Since Specialization

Citations

This map shows the geographic impact of Peter C. Wierenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Wierenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Wierenga more than expected).

Fields of papers citing papers by Peter C. Wierenga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Wierenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Wierenga. The network helps show where Peter C. Wierenga may publish in the future.

Co-authorship network of co-authors of Peter C. Wierenga

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Wierenga. A scholar is included among the top collaborators of Peter C. Wierenga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Wierenga. Peter C. Wierenga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	The effect of structured medication review followed by face-to-face feedback to prescribers on adverse drug events recognition and prevention in older inpatients – a multicenter interrupted time series study 2022 ·BMC Geriatrics ·Joanna E. Klopotowska, Paul F. M. Kuks, Peter C. Wierenga, Clementine C. M. Stuijt, L. Arisz, Marcel G. W. Dijkgraaf, Nicolette F. de Keizer, Susanne M. Smorenburg, Sophia E. de Rooij, (unknown), (unknown), (unknown), Wim G. Meijer, (unknown), A. Margot Lagaay, (unknown)	3
2	Adverse Drug Events in Older Hospitalized Patients: Results and Reliability of a Comprehensive and Structured Identification Strategy 2013 ·PLoS ONE ·Joanna E. Klopotowska, Peter C. Wierenga, Clementine C. M. Stuijt, L. Arisz, Marcel G. W. Dijkgraaf, Paul F. M. Kuks, Henk Asscheman, Evert de Jonge, Loraine Lie‐A‐Huen, Susanne M. Smorenburg, (unknown)	51
3	Frequency and nature of drug‐drug interactions in the intensive care unit 2013 ·Pharmacoepidemiology and Drug Safety ·Marjan Askari, Saied Eslami, (unknown), Peter C. Wierenga, Dave A. Dongelmans, (unknown), Ameen Abu‐Hanna	52
4	Association between Acute Geriatric Syndromes and Medication-Related Hospital Admissions 2012 ·Drugs & Aging ·Peter C. Wierenga, Bianca M. Buurman, Juliette L. Parlevliet, Barbara C. Van Munster, Susanne M. Smorenburg, Sharon K. Inouye, Sophia E. J. A. de Rooij	37
5	Recognition of adverse drug events in older hospitalized medical patients 2012 ·European Journal of Clinical Pharmacology ·(unknown), Joanna E. Klopotowska, Peter C. Wierenga, Susanne M. Smorenburg, Clementine C. M. Stuijt, L. Arisz, Paul F. M. Kuks, Marcel G. W. Dijkgraaf, Loraine Lie‐A‐Huen, Evert de Jonge	47
6	Relevance of drug-drug interaction in the ICU - perceptions of intensivists and pharmacists. 2012 ·PubMed ·Marjan Askari, Saied Eslami, (unknown), Dave A. Dongelmans, Peter C. Wierenga, (unknown), Ameen Abu‐Hanna	7
7	Association between Acute Geriatric Syndromes and Medication-Related Hospital Admissions 2012 ·Drugs & Aging ·Peter C. Wierenga, Bianca M. Buurman, Juliette L. Parlevliet, Barbara C. Van Munster, Susanne M. Smorenburg, Sharon K. Inouye, Sophia E. J. A. de Rooij	9
8	Studies pertaining to the ACOVE quality criteria: a systematic review 2011 ·International Journal for Quality in Health Care ·Marjan Askari, Peter C. Wierenga, Saied Eslami, Stephanie Medlock, Evert de Jonge, Ameen Abu‐Hanna	6
9	LERM (Logical Elements Rule Method): A method for assessing and formalizing clinical rules for decision support 2011 ·International Journal of Medical Informatics ·Stephanie Medlock, Dedan Opondo, Saeid Eslami, Marjan Askari, Peter C. Wierenga, Evert de Jonge, Ameen Abu‐Hanna	22
10	Quality Indicators for In-Hospital Pharmaceutical Care of Dutch Elderly Patients 2011 ·Drugs & Aging ·Peter C. Wierenga, Joanna E. Klopotowska, Susanne M. Smorenburg, (unknown), Yuma A. Bijleveld, Marcel G. W. Dijkgraaf, Sophia E. de Rooij	12
11	The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors) 2011 ·BMC Health Services Research ·(unknown), Joanna E. Klopotowska, Peter C. Wierenga, Sophia E. de Rooij, Clementine C. M. Stuijt, L. Arisz, Paul F. M. Kuks, Marcel G. W. Dijkgraaf, Loraine Lie‐A‐Huen, Susanne M. Smorenburg	16
12	Assessing Quality of Care of Elderly Patients Using the ACOVE Quality Indicator Set: A Systematic Review 2011 ·PLoS ONE ·Marjan Askari, Peter C. Wierenga, Saied Eslami, Stephanie Medlock, Sophia E. de Rooij, Ameen Abu‐Hanna	49
13	Clinicians satisfaction with CPOE ease of use and effect on clinicians’ workflow, efficiency and medication safety 2011 ·International Journal of Medical Informatics ·Reza Khajouei, Peter C. Wierenga, Arie Hasman, (unknown)	78
14	Pleconaril Revisited: Clinical Course of Chronic Enteroviral Meningoencephalitis after Treatment Correlates with In Vitro Susceptibility 2011 ·Antiviral Therapy ·Joanne Wildenbeest, P.J. van den Broek, Kimberley Benschop, Gerrit Koen, Peter C. Wierenga, Ann C.T.M. Vossen, Taco W. Kuijpers, Katja C. Wolthers	29
15	Towards evidence‐based pharmacotherapy in children 2010 ·Pediatric Anesthesia ·E. Marleen Kemper, Maruschka P. Merkus, Peter C. Wierenga, (unknown), (unknown), Loraine Lie‐A‐Huen, Martin Offringa	15
16	Effect of predefined order sets and usability problems on efficiency of computerized medication ordering 2010 ·International Journal of Medical Informatics ·Reza Khajouei, (unknown), Peter C. Wierenga, Marie José Kersten, (unknown)	54
17	Gebruik van procesindicatoren voor kwaliteitsmeting van farmacotherapeutische ouderenzorg bij polyfarmacie 2009 ·Data Archiving and Networked Services (DANS) ·Yuma A. Bijleveld, Peter C. Wierenga, (unknown), Susanne M. Smorenburg, Loraine Lie‐A‐Huen, Sophia E. J. A. de Rooij	1
18	Application of the Bow-Tie Model in Medication Safety Risk Analysis 2009 ·Drug Safety ·Peter C. Wierenga, Loraine Lie‐A‐Huen, Evert de Jonge, Niek Klazinga, Henk‐Jan Guchelaar, Susanne M. Smorenburg	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact